Dajing Xia Selected Research

Breast Neoplasms (Breast Cancer)

12/2021	Cholesterol-enriched membrane micro-domaindeficiency induces doxorubicin resistancevia promoting autophagy in breast cancer.
1/2021	Withdrawal: Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis.
12/2017	Association between urinary phthalate metabolites and risk of breast cancer and uterine leiomyoma.
2/2005	Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis.
1/2003	DC-CLM, a cadherin-like molecule cloned from human dendritic cells, inhibits growth of breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dajing Xia Research Topics

Disease

47	Neoplasms (Cancer) 06/2024 - 09/2002
12	Neoplasm Metastasis (Metastasis) 06/2024 - 04/2005
9	Ovarian Neoplasms (Ovarian Cancer) 11/2023 - 01/2018
7	Inflammation (Inflammations) 05/2023 - 11/2009
6	Lung Neoplasms (Lung Cancer) 02/2023 - 05/2016
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2024 - 01/2016
5	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2003
4	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 12/2014
4	Experimental Melanoma 07/2005 - 09/2002
3	Carcinogenesis 06/2024 - 04/2011
3	Sepsis (Septicemia) 01/2021 - 01/2019
3	Colonic Neoplasms (Colon Cancer) 11/2016 - 12/2013
3	Asthma (Bronchial Asthma) 03/2016 - 07/2010
2	Pterygium 01/2022 - 01/2020
2	Adenocarcinoma of Lung 08/2021 - 01/2016
2	Peritonitis 01/2021 - 01/2019
2	Parkinson Disease (Parkinson's Disease) 01/2021 - 11/2017
2	Adenocarcinoma 01/2018 - 01/2004
2	Chronic Obstructive Pulmonary Disease (COPD) 07/2015 - 12/2012
2	Necrosis 04/2011 - 04/2005
2	Carcinoma (Carcinomatosis) 08/2010 - 09/2002
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2024
1	Genomic Instability 10/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2023
1	Sarcoma (Soft Tissue Sarcoma) 02/2023
1	Ovarian Epithelial Carcinoma 01/2023
1	Head and Neck Neoplasms (Head and Neck Cancer) 11/2022
1	Squamous Cell Carcinoma of Head and Neck 11/2022
1	COVID-19 01/2022

Drug/Important Bio-Agent (IBA)

8	Long Noncoding RNAIBA 06/2024 - 01/2016
8	Proteins (Proteins, Gene)FDA Link 05/2023 - 09/2002
8	VaccinesIBA 03/2006 - 09/2003
7	AntigensIBA 01/2021 - 09/2002
5	LipopolysaccharidesIBA 01/2021 - 12/2014
5	CytokinesIBA 05/2016 - 09/2002
4	RNA (Ribonucleic Acid)IBA 11/2022 - 03/2006
4	Biomarkers (Surrogate Marker)IBA 09/2022 - 12/2014
4	InflammasomesIBA 01/2021 - 10/2016
3	Benzo(a)pyreneIBA 01/2024 - 03/2020
3	Immune Checkpoint InhibitorsIBA 02/2023 - 01/2019
3	Messenger RNA (mRNA)IBA 08/2021 - 12/2013
3	aluminum sulfate (alum)IBA 01/2021 - 10/2016
3	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2018
3	Interleukin-10 (Interleukin 10)IBA 05/2016 - 04/2011
3	InterleukinsIBA 05/2016 - 09/2003
3	Cancer VaccinesIBA 08/2010 - 09/2003
2	Phosphotransferases (Kinase)IBA 11/2023 - 01/2023
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2023 - 01/2023
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 11/2023 - 11/2017
2	Cadherins (E-Cadherin)IBA 01/2023 - 01/2003
2	bisphenol AIBA 01/2023 - 01/2018
2	CarcinogensIBA 11/2022 - 03/2020
2	Hormones (Hormone)IBA 10/2021 - 01/2018
2	mono-(2-ethylhexyl)phthalateIBA 10/2021 - 01/2021
2	Diethylhexyl Phthalate (DEHP)IBA 10/2021 - 12/2017
2	phthalic acid (phthalate)IBA 10/2021 - 12/2017
2	Insulin (Novolin)FDA Link 03/2021 - 01/2016
2	CalciumIBA 01/2021 - 01/2020
2	Growth InhibitorsIBA 01/2021 - 02/2005
2	Vitamin D FDA LinkGeneric 01/2021 - 01/2020
2	25-hydroxyvitamin DIBA 01/2021 - 01/2020
2	Endocrine DisruptorsIBA 01/2021 - 01/2018
2	LigandsIBA 01/2019 - 12/2014
2	DioxinsIBA 10/2017 - 11/2016
2	Bile Acids and Salts (Bile Acids)IBA 10/2016 - 10/2016
2	OvalbuminIBA 05/2016 - 04/2015
2	Heparin-binding EGF-like Growth Factor (HB-EGF)IBA 03/2016 - 07/2010
2	Interleukin-6 (Interleukin 6)IBA 01/2016 - 07/2015
2	Interleukin-17 (Interleukin 17)IBA 04/2015 - 07/2010
2	Poly I-CIBA 12/2014 - 11/2009
2	lymphotactinIBA 04/2011 - 09/2002
2	Interferon-gamma (Interferon, gamma)IBA 04/2011 - 07/2005
2	Peptides (Polypeptides)IBA 08/2010 - 03/2006
2	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 10/2005 - 02/2004
2	Neoplasm Antigens (Tumor Antigens)IBA 07/2005 - 04/2005
2	Interleukin-18 (Interleukin 18)IBA 06/2004 - 09/2003
2	SuperantigensIBA 02/2004 - 09/2002
1	Protein Isoforms (Isoforms)IBA 06/2024
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2024
1	DNA (Deoxyribonucleic Acid)IBA 10/2023
1	Herbal TeasIBA 01/2023
1	TeaIBA 01/2023
1	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 01/2023
1	bis(4-hydroxyphenyl)sulfoneIBA 01/2023
1	Untranslated RNA (Noncoding RNA)IBA 01/2023
1	Circular RNAIBA 01/2023
1	XenobioticsIBA 11/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2022
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 11/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2022
1	Mitogen-Activated Protein KinasesIBA 11/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022
1	pegaspargase (Oncaspar)FDA Link 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2022
1	Gemcitabine FDA Link 01/2022

Therapy/Procedure

14	Therapeutics 02/2023 - 09/2002
6	Immunotherapy 01/2022 - 09/2002
5	Drug Therapy (Chemotherapy) 11/2023 - 12/2019
2	Radiotherapy 01/2021 - 04/2005